메뉴 건너뛰기




Volumn 26, Issue 1, 2010, Pages 89-98

Neutralizing antibody titers conferring protection to macaques from a Simian/human immunodeficiency virus challenge using the TZM-bl assay

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

EID: 76449108010     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0144     Document Type: Article
Times cited : (39)

References (46)
  • 1
    • 0035815437 scopus 로고    scopus 로고
    • Control of a mucosal challenge and prevention of AIDS by a multi protein DNA/MVA vaccine
    • Amara RR, Villinger F, Altman JD, et al.: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001;292(5514):69-74.
    • (2001) Science , vol.292 , Issue.5514 , pp. 69-74
    • Amara, R.R.1    Villinger, F.2    Altman, J.D.3
  • 2
    • 0033766645 scopus 로고    scopus 로고
    • Control of viremia and prevention of clinical AIDS inrhesus monkeys by cytokine augmented DNA vaccination
    • Barouch DH, Santra S, Schmitz JE, et al.: Control of viremia andpreventionof clinicalAIDS inrhesusmonkeysbycytokineaugmented DNAvaccination. Science 2000;290(5491):486-492.
    • (2000) Science , vol.290 , Issue.5491 , pp. 486-492
    • Barouch, D.H.1    Santra, S.2    Schmitz, J.E.3
  • 3
    • 33744990609 scopus 로고    scopus 로고
    • Preserved CD4+central memory T cells and survival in vaccinated SIV-challenged monkeys
    • Letvin NL, Mascola JR, Sun Y, et al.: Preserved CD4+central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006;312(5779):1530-1533.
    • (2006) Science , vol.312 , Issue.5779 , pp. 1530-1533
    • Letvin, N.L.1    Mascola, J.R.2    Sun, Y.3
  • 4
    • 33744902339 scopus 로고    scopus 로고
    • Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
    • Wilson NA, Reed J, Napoe GS, et al.: Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 2006;80(12): 5875-5885.
    • (2006) J Virol , vol.80 , Issue.12 , pp. 5875-5885
    • Wilson, N.A.1    Reed, J.2    Napoe, G.S.3
  • 5
    • 29244455769 scopus 로고    scopus 로고
    • Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag
    • Casimiro DR, Wang F, Schleif WA, et al.: Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 2005;79(24): 15547-15555.
    • (2005) J Virol , vol.79 , Issue.24 , pp. 15547-15555
    • Casimiro, D.R.1    Wang, F.2    Schleif, W.A.3
  • 6
    • 58149267963 scopus 로고    scopus 로고
    • Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
    • Liu J, O'Brien KL, Lynch DM, et al.: Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009;457(7225):87-91.
    • (2009) Nature , vol.457 , Issue.7225 , pp. 87-91
    • Liu, J.1    O'Brien, K.L.2    Lynch, D.M.3
  • 7
    • 0034093217 scopus 로고    scopus 로고
    • Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV
    • Ourmanov I, Brown CR, Moss B, et al.: Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. J Virol 2000; 74(6):2740-2751.
    • (2000) J Virol , vol.74 , Issue.6 , pp. 2740-2751
    • Ourmanov, I.1    Brown, C.R.2    Moss, B.3
  • 8
    • 0033524838 scopus 로고    scopus 로고
    • Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
    • Schmitz JE, Kuroda MJ, Santra S, et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283(5403):857-860.
    • (1999) Science , vol.283 , Issue.5403 , pp. 857-860
    • Schmitz, J.E.1    Kuroda, M.J.2    Santra, S.3
  • 9
    • 0037122719 scopus 로고    scopus 로고
    • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
    • Shiver JW, Fu TM, Chen L, et al.: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency- virus immunity. Nature 2002;415(6869):331-335.
    • (2002) Nature , vol.415 , Issue.6869 , pp. 331-335
    • Shiver, J.W.1    Fu, T.M.2    Chen, L.3
  • 10
    • 38149096202 scopus 로고    scopus 로고
    • Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
    • Barnett SW, Srivastava IK, Kan E, et al.: Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS 2008;22(3):339-348.
    • (2008) AIDS , vol.22 , Issue.3 , pp. 339-348
    • Barnett, S.W.1    Srivastava, I.K.2    Kan, E.3
  • 11
    • 0035124098 scopus 로고    scopus 로고
    • Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques
    • Cho MW, Kim YB, Lee MK, et al.: Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques. J Virol 2001;75(5):2224-2234.
    • (2001) J Virol , vol.75 , Issue.5 , pp. 2224-2234
    • Cho, M.W.1    Kim, Y.B.2    Lee, M.K.3
  • 12
    • 0033952103 scopus 로고    scopus 로고
    • Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
    • Baba TW, Liska V, Hofmann-Lehmann R, et al.: Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000;6(2):200-206.
    • (2000) Nat Med , vol.6 , Issue.2 , pp. 200-206
    • Baba, T.W.1    Liska, V.2    Hofmann-Lehmann, R.3
  • 13
    • 0032947286 scopus 로고    scopus 로고
    • Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
    • Mascola JR, Lewis MG, Stiegler G, et al.: Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 1999;73(5):4009-4018.
    • (1999) J Virol , vol.73 , Issue.5 , pp. 4009-4018
    • Mascola, J.R.1    Lewis, M.G.2    Stiegler, G.3
  • 14
    • 0033951746 scopus 로고    scopus 로고
    • Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
    • Mascola JR, Stiegler G, VanCott TC, et al.: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000;6(2):207-210.
    • (2000) Nat Med , vol.6 , Issue.2 , pp. 207-210
    • Mascola, J.R.1    Stiegler, G.2    Vancott, T.C.3
  • 15
    • 0036170921 scopus 로고    scopus 로고
    • Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies
    • Nishimura Y, Igarashi T, Haigwood N, et al.: Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 2002;76(5):2123-2130.
    • (2002) J Virol , vol.76 , Issue.5 , pp. 2123-2130
    • Nishimura, Y.1    Igarashi, T.2    Haigwood, N.3
  • 16
    • 0034864776 scopus 로고    scopus 로고
    • Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
    • Parren PW, Marx PA, Hessell AJ, et al.: Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 2001;75(17): 8340-8347.
    • (2001) J Virol , vol.75 , Issue.17 , pp. 8340-8347
    • Parren, P.W.1    Marx, P.A.2    Hessell, A.J.3
  • 17
    • 0032907674 scopus 로고    scopus 로고
    • Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
    • Shibata R, Igarashi T, Haigwood N, et al.: Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 1999;5(2):204-210.
    • (1999) Nat Med , vol.5 , Issue.2 , pp. 204-210
    • Shibata, R.1    Igarashi, T.2    Haigwood, N.3
  • 19
    • 29444442970 scopus 로고    scopus 로고
    • Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
    • Frost SD, Wrin T, Smith DM, et al.: Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci USA 2005;102(51):18514-18519.
    • (2005) Proc Natl Acad Sci USA , vol.102 , Issue.51 , pp. 18514-18519
    • Frost, S.D.1    Wrin, T.2    Smith, D.M.3
  • 20
    • 0037389643 scopus 로고    scopus 로고
    • Rapid evolution of the neutralizing antibody response to HIV type 1 infection
    • Richman DD, Wrin T, Little SJ, and Petropoulos CJ: Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003;100(7):4144-4149.
    • (2003) Proc Natl Acad Sci USA , vol.100 , Issue.7 , pp. 4144-4149
    • Richman, D.D.1    Wrin, T.2    Little, S.J.3    Petropoulos, C.J.4
  • 21
    • 0037456827 scopus 로고    scopus 로고
    • Antibody neutralization and escape by HIV-1
    • Wei X, Decker JM, Wang S, et al.: Antibody neutralization and escape by HIV-1. Nature 2003;422(6929):307-312.
    • (2003) Nature , vol.422 , Issue.6929 , pp. 307-312
    • Wei, X.1    Decker, J.M.2    Wang, S.3
  • 22
    • 1542317452 scopus 로고    scopus 로고
    • HIV vaccine design and the neutralizing antibody problem
    • Burton DR, Desrosiers RC, Doms RW, et al.: HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004;5(3):233-236.
    • (2004) Nat Immunol , vol.5 , Issue.3 , pp. 233-236
    • Burton, D.R.1    Desrosiers, R.C.2    Doms, R.W.3
  • 23
    • 34948854718 scopus 로고    scopus 로고
    • Broad HIV-1 neutralization mediated by CD4-binding site antibodies
    • Li Y, Migueles SA, Welcher B, et al.: Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 2007;13(9):1032-1034.
    • (2007) Nat Med , vol.13 , Issue.9 , pp. 1032-1034
    • Li, Y.1    Migueles, S.A.2    Welcher, B.3
  • 24
    • 63849131879 scopus 로고    scopus 로고
    • Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
    • Scheid JF, Mouquet H, Feldhahn N, et al.: Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009;458(7238):636-640.
    • (2009) Nature , vol.458 , Issue.7238 , pp. 636-640
    • Scheid, J.F.1    Mouquet, H.2    Feldhahn, N.3
  • 25
    • 43249120051 scopus 로고    scopus 로고
    • Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models
    • Brown BK, Wieczorek L, Sanders-Buell E, et al.: Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. Virology 2008;375(2):529-538.
    • (2008) Virology , vol.375 , Issue.2 , pp. 529-538
    • Brown, B.K.1    Wieczorek, L.2    Sanders-Buell, E.3
  • 26
    • 0027985431 scopus 로고
    • Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
    • Burton DR, Pyati J, Koduri R, et al.: Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994;266(5187):1024-1027.
    • (1994) Science , vol.266 , Issue.5187 , pp. 1024-1027
    • Burton, D.R.1    Pyati, J.2    Koduri, R.3
  • 27
    • 23244434512 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
    • Li M, Gao F, Mascola JR, et al.: Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005;79(16):10108-10125.
    • (2005) J Virol , vol.79 , Issue.16 , pp. 10108-10125
    • Li, M.1    Gao, F.2    Mascola, J.R.3
  • 28
    • 43249120426 scopus 로고    scopus 로고
    • Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
    • Polonis VR, Brown BK, Rosa Borges A, et al.: Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 2008;375(2):315-320.
    • (2008) Virology , vol.375 , Issue.2 , pp. 315-320
    • Polonis, V.R.1    Brown, B.K.2    Rosa Borges, A.3
  • 29
    • 0029815226 scopus 로고    scopus 로고
    • Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type1 envelopeproducedfrominfectedprimaryT-lymphocyte and macrophage cultures
    • Willey RL, Shibata R, Freed EO, Cho MW, and Martin MA: Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type1 envelopeproducedfrominfectedprimaryT- lymphocyte and macrophage cultures. J Virol 1996;70(9):6431-6436.
    • (1996) J Virol , vol.70 , Issue.9 , pp. 6431-6436
    • Willey, R.L.1    Shibata, R.2    Freed, E.O.3    Cho, M.W.4    Martin, M.A.5
  • 30
    • 0029951823 scopus 로고    scopus 로고
    • Vaccine protection by a triple deletion mutant of simian immunodeficiency virus
    • Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, and Desrosiers RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70(6): 3724-3733.
    • (1996) J Virol , vol.70 , Issue.6 , pp. 3724-3733
    • Wyand, M.S.1    Manson, K.H.2    Garcia-Moll, M.3    Montefiori, D.4    Desrosiers, R.C.5
  • 31
    • 33745158157 scopus 로고
    • A simple method of estimating fifty percent endpoints
    • Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497.
    • (1938) Am J Hyg , vol.27 , pp. 493-497
    • Reed, L.J.1    Muench, H.2
  • 32
    • 0030855058 scopus 로고    scopus 로고
    • Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing
    • Shibata R, Maldarelli F, Siemon C, et al.: Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing. J Infect Dis 1997;176(2):362-373.
    • (1997) J Infect Dis , vol.176 , Issue.2 , pp. 362-373
    • Shibata, R.1    Maldarelli, F.2    Siemon, C.3
  • 33
    • 0029018332 scopus 로고
    • Isolation and characterization of a syncytium-inducing, macrophage/ T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo
    • Shibata R, Hoggan MD, Broscius C, et al.: Isolation and characterization of a syncytium-inducing, macrophage/ T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol 1995;69(7):4453-4462.
    • (1995) J Virol , vol.69 , Issue.7 , pp. 4453-4462
    • Shibata, R.1    Hoggan, M.D.2    Broscius, C.3
  • 34
    • 0004116672 scopus 로고    scopus 로고
    • 3d ed. Cambridge University Press, Cambridge, England
    • Finney DJ: Probit Analysis, 3d ed. Cambridge University Press, Cambridge, England, 2007.
    • (2007) Probit Analysis
    • Finney, D.J.1
  • 36
    • 56449131391 scopus 로고    scopus 로고
    • Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
    • Binley JM, Lybarger EA, Crooks ET, et al.: Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol 2008;82(23):11651-11668.
    • (2008) J Virol , vol.82 , Issue.23 , pp. 11651-11668
    • Binley, J.M.1    Lybarger, E.A.2    Crooks, E.T.3
  • 37
    • 34249952292 scopus 로고    scopus 로고
    • Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
    • Kraft Z, Derby NR, McCaffrey RA, et al.: Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J Virol 2007;81(12):6402-6411.
    • (2007) J Virol , vol.81 , Issue.12 , pp. 6402-6411
    • Kraft, Z.1    Derby, N.R.2    McCaffrey, R.A.3
  • 38
    • 58149487629 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein
    • Morner A, Douagi I, Forsell MN, et al.: Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein. J Virol 2009;83(2):540-551.
    • (2009) J Virol , vol.83 , Issue.2 , pp. 540-551
    • Morner, A.1    Douagi, I.2    Forsell, M.N.3
  • 39
    • 23844467017 scopus 로고    scopus 로고
    • HIV-1 envelope pseudo typed viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity
    • Louder MK, Sambor A, Chertova E, et al.: HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 2005;339(2):226-238.
    • (2005) Virology , vol.339 , Issue.2 , pp. 226-238
    • Louder, M.K.1    Sambor, A.2    Chertova, E.3
  • 40
    • 69449087173 scopus 로고    scopus 로고
    • HIV sensitivity to neutralization is determined by target and virus producer cell properties
    • Mann AM, Rusert P, Berlinger L, Kuster H, Gunthard HF, and Trkola A: HIV sensitivity to neutralization is determined by target and virus producer cell properties. AIDS 2009;23(13):1659-1667.
    • (2009) AIDS , vol.23 , Issue.13 , pp. 1659-1667
    • Mann, A.M.1    Rusert, P.2    Berlinger, L.3    Kuster, H.4    Gunthard, H.F.5    Trkola, A.6
  • 41
    • 0034958413 scopus 로고    scopus 로고
    • Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells
    • Forthal DN, Landucci G, and Daar ES: Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 2001;75(15):6953-6961.
    • (2001) J Virol , vol.75 , Issue.15 , pp. 6953-6961
    • Forthal, D.N.1    Landucci, G.2    Daar, E.S.3
  • 42
    • 0033375327 scopus 로고    scopus 로고
    • Antibody dependent cellular cytotoxicity independently predicts survival in severely immuno compromised human immunodeficiency virus-infected patients
    • Forthal DN, Landucci G, Haubrich R, et al.: Antibodydependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. J Infect Dis 1999; 180(4):1338-1341.
    • (1999) J Infect Dis , vol.180 , Issue.4 , pp. 1338-1341
    • Forthal, D.N.1    Landucci, G.2    Haubrich, R.3
  • 43
    • 13544277161 scopus 로고    scopus 로고
    • Vaccine elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251
    • Gomez-Roman VR, Patterson LJ, Venzon D, et al.: Vaccineelicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 2005;174(4):2185-2189.
    • (2005) J Immunol , vol.174 , Issue.4 , pp. 2185-2189
    • Gomez-Roman, V.R.1    Patterson, L.J.2    Venzon, D.3
  • 44
    • 34548496893 scopus 로고    scopus 로고
    • Fc receptor but not complement binding is important in antibody protection against HIV
    • Hessell AJ, Hangartner L, Hunter M, et al.: Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007;449(7158):101-104.
    • (2007) Nature , vol.449 , Issue.7158 , pp. 101-104
    • Hessell, A.J.1    Hangartner, L.2    Hunter, M.3
  • 45
    • 57349169315 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 super infection occurs despite relatively robust neutralizing antibody responses
    • Blish CA, Dogan OC, Derby NR, et al.: Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses. J Virol 2008;82(24): 12094-12103.
    • (2008) J Virol , vol.82 , Issue.24 , pp. 12094-12103
    • Blish, C.A.1    Dogan, O.C.2    Derby, N.R.3
  • 46
    • 38349147390 scopus 로고    scopus 로고
    • In vivo efficacy of human immunodeficiency virus neutralizing antibodies: Estimates for protective titers
    • Trkola A, Kuster H, Rusert P, et al.: In vivo efficacy of human immunodeficiency virus neutralizing antibodies: Estimates for protective titers. J Virol 2008;82(3):1591-1599.
    • (2008) J Virol , vol.82 , Issue.3 , pp. 1591-1599
    • Trkola, A.1    Kuster, H.2    Rusert, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.